This is the authors' abstract. We don't add key points for this paper.
Senescent cells contribute to tissue dysfunction and the progression of age-related diseases. Senolytic therapies, which selectively eliminate these cells, have demonstrated beneficial effects in preclinical models by restoring tissue function and delaying age-related decline. Naturally occurring compounds are gaining attention due to their structural diversity and low toxicity. Among these, triterpenes, plant-derived molecules with anti-inflammatory and protective properties, are emerging as therapeutic candidates for targeting cellular senescence. Here, we aimed to evaluate the senolytic activity of β-amyrin, a plant-derived triterpene, in established fibroblast models. Using senescent cells of murine and human origin, we found that β-amyrin selectively induced cell death in senescent cells. Mechanistic analyses suggest that this effect involves cannabinoid receptor 2 signaling and proceeds independently of caspase activation. These findings highlight β-amyrin as a promising senolytic compound with a potentially unique mechanism of action.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Hirose et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: